Login / Signup

Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India.

Swaminathan SubramanianPurushothaman JambulingamKaliannagounder KrishnamoorthyNeelavathi SivagnanameCandasamy SadanandaneVenkatesan VasukiChokkalingam PalaniswamyBalakrishnan VijayakumarAdinarayanan SrividyaHari Kishan K Raju
Published in: PLoS neglected tropical diseases (2020)
The result of MX protocol was in good agreement with that of TAS, providing evidence to recommend MX as a complementary tool to TAS to decide on stopping MDA. MX can also be a potential surveillance tool for post-MDA and post-validation phases as it could detect sites with residual infection and risk of resurgence of transmission. MX is economically feasible as its cost is slightly higher than that of TAS.
Keyphrases
  • breast cancer cells
  • public health
  • cell cycle arrest
  • study protocol
  • clinical trial
  • single molecule